This is the authors' abstract. We don't add key points for this paper.
Abstract Cell type-specific (CTS) analysis is crucial for uncovering biological insights hidden in bulk tissue data, yet single-cell (sc) or single-nuclei (sn) approaches are often cost-prohibitive for large samples. We introduce EPIC-unmix, a novel two-step empirical Bayesian method combining reference sc/sn and bulk RNA-seq data to improve CTS inference, accounting for the difference between reference and target datasets. Under comprehensive simulations, EPIC-unmix outperformed alternative methods in accuracy. Applied to Alzheimer's disease (AD) brain RNA-seq data, EPIC-unmix identified multiple differentially expressed genes in a CTS manner, and empowered CTS eQTL analysis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: